Insider Transactions in Q4 2021 at Keros Therapeutics, Inc. (KROS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
735
-0.85%
|
$36,750
$50.0 P/Share
|
|
Dec 15
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
735
+0.84%
|
$0
$0.3 P/Share
|
|
Dec 13
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,915
-0.73%
|
$97,665
$51.99 P/Share
|
|
Dec 13
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,915
+2.14%
|
$0
$0.3 P/Share
|
|
Dec 02
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
25,338
-0.98%
|
$1,342,914
$53.42 P/Share
|
|
Dec 01
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
22,313
-0.84%
|
$1,227,215
$55.03 P/Share
|
|
Nov 11
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,300
-2.93%
|
$312,700
$59.25 P/Share
|
|
Nov 11
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+5.5%
|
$0
$0.3 P/Share
|
|
Nov 10
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,900
-15.65%
|
$954,000
$60.0 P/Share
|
|
Nov 10
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,900
+13.53%
|
$0
$0.3 P/Share
|
|
Nov 04
2021
|
Jennifer Lachey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,600
-11.01%
|
$530,000
$50.0 P/Share
|
|
Nov 04
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,600
+9.92%
|
$0
$0.3 P/Share
|
|
Nov 03
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
15,967
-1.17%
|
$670,614
$42.05 P/Share
|
|
Nov 02
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
7,881
-0.57%
|
$331,002
$42.57 P/Share
|
|
Nov 01
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
23,803
-1.67%
|
$999,726
$42.14 P/Share
|
|
Oct 20
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
4,082
-0.28%
|
$151,034
$37.93 P/Share
|
|
Oct 19
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
4,516
-0.31%
|
$171,608
$38.27 P/Share
|
|
Oct 18
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
13,786
-0.93%
|
$523,868
$38.07 P/Share
|
|
Oct 15
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
8,198
-0.37%
|
$319,722
$39.66 P/Share
|
|
Oct 14
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
4,383
-0.58%
|
$175,320
$40.13 P/Share
|
|
Oct 05
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
2,617
-0.35%
|
$104,680
$40.03 P/Share
|
|
Oct 04
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
3,746
-0.49%
|
$149,840
$40.06 P/Share
|
|
Oct 01
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
6,323
-0.82%
|
$252,920
$40.16 P/Share
|